Acrobiosystems for English
icon_bulk_orderBulk inquiry/Quick order
0
There is no goods in the shopping cart !
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0-9
Your Position: Home > GP41

GP41

Brief Information

Name:Transmembrane glycoprotein gp41
Target Synonym:Submitted name: Transmembrane glycoprotein gp41,env,HIV Envelope Protein gp41,Env polyprotein
Number of Launched Drugs:2
Number of Drugs in Clinical Trials:8
Lastest Research Phase:Approved

Product ListCompare or Buy

By Product Status:
By Product Category:
By Species:
By Tag:
By Conjugate:
Cat. No. Species Product Description Structure Purity Feature
GP1-H51H3 HIV-1 (HXB2) HIV-1 (HXB2) GP41 Pre-hairpin intermediate Protein, His Tag
GP1-H51H3-structure
GP1-H51H3-sds
ACRO Quality

Part of Bioactivity data

GP1-H51H3-SPR
 GP41 SPR

Monoclonal Anti-HIV-1 GP41 Antibody, Human IgG1 (2F5) captured on Protein A Chip can bind HIV-1 (HXB2) GP41 Pre-hairpin intermediate Protein, His Tag (Cat. No. GP1-H51H3) with an affinity constant of 0.468 nM as determined in a SPR assay (Biacore 8K) (Routinely tested).

GP1-H51H3-ELISA
 GP41 ELISA

Immobilized HIV-1 (HXB2) GP41 Pre-hairpin intermediate Protein, His Tag (Cat. No. GP1-H51H3) at 1 μg/mL (100 μL/well) can bind Monoclonal Anti-HIV-1 GP41 Antibody, Human IgG1 (2F5) with a linear range of 0.2-16 ng/mL (QC tested).

Public Drug Information

Name Research Code Research Phase Company First Brand Name First Approved Country First Indication First Approved Company First Approved Date Indications Clinical Trials
Enfuvirtide T-20; R-698; DP-178 Approved F. Hoffmann-La Roche Ltd Fuzeon United States HIV Infections F. Hoffmann-La Roche Ltd 2003-03-13 HIV Infections; Acquired Immunodeficiency Syndrome; HIV Seropositivity Details
Albuvirtide FB-006M Approved Frontier Biotechnologies Inc 艾可宁 Mainland China HIV Infections Frontier Biotechnologies Inc 2018-05-23 Acquired Immunodeficiency Syndrome; HIV Infections Details

Clinical Drug Information

Name Research Code Research Phase Company Indications Clinical Trials
PGT-121 PGT-121 Phase 2 Clinical International Aids Vaccine Initiative, Theraclone Sciences Inc, The Scripps Research Institute Inc, The Ragon Institute Of Mgh, Mit And Harvard HIV Infections; Acquired Immunodeficiency Syndrome; Retroviridae Infections; Sexually Transmitted Diseases, Viral; HIV Seropositivity Details
Microbicide monoclonal antibody triple combination (Polymun Scientific Immunobiologische Forschung) Phase 1 Clinical Polymun Scientific Gmbh HIV Infections Details
SAR-441236 (National Institute of Allergy and Infectious Diseases) SAR-441236 Phase 1 Clinical National Institute Of Allergy And Infectious Diseases (Niaid), Sanofi, The Scripps Research Institute Inc, National Institutes Of Health HIV Infections Details
Sifuvirtide FS-0101; SFT Phase 2 Clinical Tianjin Fusogen Pharmaceuticals Inc HIV Infections; Acquired Immunodeficiency Syndrome Details
FB-1002(Frontier Biotechnologies) FB-1002(前沿生物) Phase 1 Clinical Frontier Biotechnologies Inc, Shanghai Institute Of Materia Medica, Chinese Academy Of Sciences Coronavirus Disease 2019 (COVID-19) Details
MPER-656 liposome vaccine MPER-656 Phase 1 Clinical National Institute Of Allergy And Infectious Diseases (Niaid) HIV Infections Details
Elipovimab GS-9722 Phase 1 Clinical Gilead Inc HIV Infections Details
CPT-31 CPT-31; CPT31-LA Phase 1 Clinical Navigen Purpura, Thrombocytopenic, Idiopathic; HIV Infections Details

This web search service is supported by Google Inc.

totop
Call us
Call us
North America:
+1 800-810-0816 (Toll Free)
Asia & Pacific:
+86 400-682-2521
Fax
Fax
+1 888-377-6111
Address
Address
1 Innovation Way, Newark, DE 19711, USA

Leave a message